147 results
Page 2 of 8
8-K
EX-99.1
2ahijbl1 gcy1
5 Jun 23
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
8:32am
8-K
EX-99.1
chcs j4157
11 May 23
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
6:20am
PRE 14A
a7iy267h2yq1fgxfhf
21 Apr 23
Preliminary proxy
4:00pm
8-K
EX-99.2
8mri3lc
15 Dec 22
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
8:31am
8-K
EX-99.1
kzs726o9mbnsy
15 Dec 22
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
8:31am
8-K
EX-99.1
peixaqhpnir903m3t2
30 Nov 22
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
4:20pm
8-K
EX-99.1
su5rlz
10 Nov 22
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update
6:27am
8-K
EX-99.2
cpm orb41
18 Oct 22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
8:30am
8-K
EX-99.1
x9gszvxm93x7zyf oj
18 Oct 22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
8:30am
8-K
EX-99.1
6blyhj8zxbwm92n
11 Aug 22
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update
6:31am
8-K
EX-99.1
6d8amx10qmdc7uif
12 May 22
Synlogic Reports First Quarter 2022 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
p7pb5
17 Mar 22
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:36am
8-K
EX-99.2
tfy 2w8l4
17 Mar 22
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:36am